MMS

MMS is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach.

MMS Holdings (MMS) is an innovative, data-focused CRO that supports the pharmaceutical, biotech, and medical device industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating, and the company has been recognized as a leading CRO in Global Health & Pharma’s international awards programs for three consecutive years.

01/05/2026

What skills will define successful medical writers as AI becomes a core part of daily workflows?

This question came up during a recent conversation, and the answer sparked one of the strongest discussions of the entire webinar. Listen to this quick clip that captures the moment where we explore how writers can grow, adapt, and strengthen their value as technology accelerates.

Explore the full on-demand session to gain real-world use cases and practical guidance now: https://hubs.li/Q03YJ5Rf0

Thanks to Dr. Teresa Cesena for her expertise in answering this question!

01/02/2026

New year. New job? If you are looking for a place where science, data expertise, and meaningful impact come together, MMS may be the next step in your career.

Our teams across the globe work on programs that advance global health, and as we continue to grow, we are looking for talent in biometrics, medical writing, regulatory strategy, data science, clinical development operations, and technology.

MMS offers the opportunity to collaborate with skilled colleagues, contribute to important research, and build a career with purpose. Explore open roles and consider starting your next chapter with MMS here: https://hubs.li/Q03YJ7Cs0

01/01/2026

Happy New Year from MMS! Our global teams are ready to begin 2026 with the right focus and a clear commitment to advancing high-quality clinical development for sponsors and patients worldwide.

The work ahead will demand strong science, thoughtful use of technology, and close collaboration across teams and partners. MMS enters the new year with the experience, talent, and vision needed to deliver clarity and reliability at every step of the drug development process.

Thank you to our colleagues, clients, and partners for your trust and support! We look forward to continuing our work together to bring meaningful therapies closer to the patients who rely on them.

Wishing you a successful and inspiring start to 2026!

12/31/2025

One of our latest Perspectives articles gathers insights to understand what the past year revealed and what pharma and biotech sponsors can do to build stronger programs in 2026! Moving forward, leaders within MMS are agreeing on five approaches:

✅ Build Programs That Can Absorb Change
✅ Use AI Thoughtfully and Transparently
✅ Treat CROs as Scientific Partners
✅ Invest in Evidence That Stands Up to Scrutiny
✅ Prioritize Efficiency Through Better Design and Better Data

Read the full insights here and let us know what resonates most with you: https://hubs.li/Q03YQVGb0

12/30/2025

Clinical Development Is Transforming—Are You Prepared?

As trial designs grow more complex and data sources multiply, sponsors face mounting pressure to design smarter trials, reduce failure rates, and make confident decisions earlier. Yet many challenges—flawed protocols, delayed insights, unnecessary rework—are preventable with the right technology and expertise.

Join our webinar to explore three game-changing technologies shaping the future of clinical trials:
✅ Data-driven modeling & simulation
✅ Integrated analytics for in-stream decision-making
✅ AI-powered clinical workflows

Industry leaders Irving Dark, Chris Schoonmaker, and Stephine Keeton will share real-world use cases and strategic guidance to help sponsors:
✔ Enhance feasibility assessments
✔ De-risk design choices
✔ Optimize operational performance
✔ Accelerate milestones from planning to submission

📅 Don’t miss this opportunity to future-proof your clinical development.
👉 https://hubs.li/Q03YJ7-q0

12/29/2025

AI has become commonplace in many aspects of daily life, and as part of overall life sciences transformation, medical writers need to adapt to using and eventually leveraging these AI tools to improve the writing process.

Read this article to understand the following:
👉 Current Uses and Importance of AI in Medical Writing
👉 Advantages and Challenges of AI in Medical Writing
👉 AI Pilot Projects & Best Practices
👉 What’s Next for AI in Medical Writing?

Learn from Lucy Sutton, Teresa Cesena, James Newman, and our partners at TrialAssure here: https://hubs.li/Q03YfTz50

12/24/2025

As large language models evolve, medical writers and sponsors continue to ask the same question: Which models can be trusted, and how do we reduce the risk of errors?

This moment from our AI medical writing webinar breaks down how writers can evaluate LLM reliability and what teams can do to strengthen oversight and verification. The short clip provides a clear look at the practical steps that matter most.

Watch the clip to hear from our partner Zach Weingarden at TrialAssure, then explore the full on-demand session to learn how these approaches support safer and more effective AI adoption: https://hubs.li/Q03YfCMj0

12/23/2025

Happy holiday season from everyone at MMS! We are grateful for our colleagues, clients, and partners who helped make 2025 a year of meaningful progress.

Our spirited teams across the US, Europe, India, and South Africa brought focus, creativity, and dedication to every project this year. The work we do together supports stronger evidence, clearer decisions, and better paths forward for patients who depend on new treatment options.

As we close out the year, we want to thank you for your trust and collaboration! We look forward to building on this momentum in 2026 with a continued commitment to high-quality science and reliable delivery.

Wishing you a safe, joyful, and restful holiday season from all of us at !

12/19/2025

How will regulatory change shape sponsor strategy in 2026? This end-of-year retrospective brings forward the themes that arose in recent industry conversations, including how sponsors can navigate a landscape driven by regulatory movement, tighter budgets, and higher data expectations.

Within the article, CEO Dr. Uma Sharma notes that “sponsors wanted thought and ex*****on partners who could help them align scientific, operational, and data-driven strategies in an unpredictable space. From our experience, regulatory flux made that alignment even more pressing.”

Read the full insights here and let us know what resonates most with you: https://hubs.li/Q03YfJSB0

12/17/2025

AI is shaping clinical biometrics faster than anyone expected, and the conversations happening across data management, biostatistics, and statistical programming show that teams are preparing for a very different future.

Our latest blog article recaps key insights shared by Satya Ingle at a 2025 PHUSE Single Day Event, including what AI singularity could mean for biometrics roles, workflows, and the skills teams will need to grow.

“One of the most important ideas is Symbiotic Intelligence, where AI accelerates production and humans guide strategy and interpretation. This balance helps teams grow capabilities that were not imagined before.”

If you are thinking about the future of biometrics or exploring how AI fits into your team’s work, this is worth a read: https://hubs.li/Q03YfQHn0

12/16/2025

Celebrating Partnerships with Purpose

As 2025 draws to a close, we’re saying a heartfelt thank you to our clients and partners. To mark the season and our shared commitment to positive action, MMS has planted trees on behalf of our customers through https://hubs.li/Q03YhSWT0

Our roots run deep, and this gesture reflects our appreciation for our clients' trust and collaboration. Here’s to continued success together in 2026!

12/16/2025

What will shape pharma and biotech the most in 2026? We spent time breaking down conversations and insights shared by MMS leaders to understand what influenced development decisions in 2025 and where sponsors see the strongest opportunities ahead.

One of the clearest industry-wide patterns was the dramatic rise in curiosity around AI. Leaders across pharma expressed a desire to innovate, yet many had limited clarity on how AI should be implemented. CIO Mohamad Zahreddine described the situation as, “an overwhelming wave that sometimes added fog instead of insight. Many organizations knew they needed AI but had no clear path for starting or scaling.”

Read the full insights here and let us know what resonates most with you: https://hubs.li/Q03YfHDs0

Address

6880 Commerce Boulevard
Canton, MI
48187

Telephone

+17342450310

Website

http://www.mmsholdings.com/

Alerts

Be the first to know and let us send you an email when MMS posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to MMS:

Shortcuts

Want your practice to be the top-listed Clinic in Canton?

Our Story

MMS is an award-winning, data-focused CRO that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience and a data-driven approach to drug development make MMS a valuable CRO partner, creating compelling submissions that meet rigorous regulatory standards. With a global footprint across four continents, MMS maintains a 97 percent customer satisfaction rating and was named as the Best Global Biotech CRO in the 2018 International Life Sciences Awards.

01/05/2026

01/02/2026

01/01/2026

12/31/2025

12/30/2025

12/29/2025

12/24/2025

12/23/2025

12/19/2025

12/17/2025

12/16/2025

12/16/2025

Address

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share

Our Story